“Clearly, the cross-reactivity of spironolactone with the androstenedione assay in this patient was higher than that quoted by the manufacturer.”
“It was concluded that spironolactone had interfered with the measurement of androstenedione using the Direct Androstenedione Coat-A-Count (CAC) radioimmunoassay (Siemens Healthcare).”
“The manufacturer suggests that the cross-reaction of spironolactone with androstenedione in this assay is 0 109%; this implies that our patient’s blood spironolactone concentration would have to have been greater than 4000 ng/ml to give this androstenedione result through interference.”